Zhang Meihua, Kim Hoe Suk, Jin Tiefeng, Woo Jisu, Piao Yin Ji, Moon Woo Kyung
Department of Radiology, Seoul National University Hospital, Jongno-gu, Seoul 03080, Korea.
Department of Biomedical Sciences, Seoul National University College of Medicine, Jongno-gu, Seoul 110-799, Korea.
Oncotarget. 2017 Sep 23;8(49):86566-86575. doi: 10.18632/oncotarget.21243. eCollection 2017 Oct 17.
Current EGFR-targeted therapy for triple negative breast cancer (TNBC) has produced disappointing results. A rational therapeutic strategy to improve EGFR-targeted treatment for TNBC is therefore needed. In this study we evaluated the feasibility of treating TNBC using photoacoustic imaging (PAI)-guided near-infrared photothermal therapy (NIR-PTT) with anti-EGFR-conjugated gold nanorods (anti-EGFR-GN). NIR-PTT combined with anti-EGFR-GN exerted synergistic anti-proliferative and apoptotic actions through upregulation of HSP70 and cleaved caspase-3, downregulation of Ki-67 and EGFR, and inhibition of several intracellular signaling molecules (mTOR, AKT, ERK1/2 and FAK). These combined effects give this approach significant efficacy. Our findings suggest PAI-guided NIR-PTT using anti-EGFR-GN represent a novel and effective strategy for EGFR-targeted therapy in TNBC.
目前针对三阴性乳腺癌(TNBC)的表皮生长因子受体(EGFR)靶向治疗效果令人失望。因此,需要一种合理的治疗策略来改善TNBC的EGFR靶向治疗。在本研究中,我们评估了使用光声成像(PAI)引导的近红外光热疗法(NIR-PTT)联合抗EGFR偶联金纳米棒(anti-EGFR-GN)治疗TNBC的可行性。NIR-PTT联合anti-EGFR-GN通过上调热休克蛋白70(HSP70)和裂解的半胱天冬酶-3(cleaved caspase-3)、下调Ki-67和EGFR以及抑制几种细胞内信号分子(哺乳动物雷帕霉素靶蛋白(mTOR)、蛋白激酶B(AKT)、细胞外信号调节激酶1/2(ERK1/2)和黏着斑激酶(FAK))发挥协同抗增殖和凋亡作用。这些联合效应赋予了这种方法显著的疗效。我们的研究结果表明,使用anti-EGFR-GN的PAI引导的NIR-PTT是TNBC中EGFR靶向治疗的一种新型有效策略。
J Photochem Photobiol B. 2017-3-30
ACS Appl Mater Interfaces. 2017-4-18
Pharmaceutics. 2023-1-11
Molecules. 2019-9-30
J Photochem Photobiol B. 2017-3-30
J Biomed Nanotechnol. 2016-3
Annu Rev Biomed Eng. 2014-7-11